SCM

Sio Capital Management Portfolio holdings

AUM $249M
1-Year Return 117.71%
This Quarter Return
+13.59%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$328M
AUM Growth
+$67.2M
Cap. Flow
+$44.1M
Cap. Flow %
13.47%
Top 10 Hldgs %
41.01%
Holding
89
New
15
Increased
27
Reduced
12
Closed
21

Top Buys

1
BIIB icon
Biogen
BIIB
$18.6M
2
CVS icon
CVS Health
CVS
$12M
3
GSK icon
GSK
GSK
$10.9M
4
ASND icon
Ascendis Pharma
ASND
$10.6M
5
GMED icon
Globus Medical
GMED
$10M

Top Sells

1
COR icon
Cencora
COR
$9.97M
2
CI icon
Cigna
CI
$9.92M
3
CAH icon
Cardinal Health
CAH
$9.32M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
$7.05M
5
CELG
Celgene Corp
CELG
$6.56M

Sector Composition

1 Healthcare 90.58%
2 Industrials 1.25%
3 Technology 0.41%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
IDXG
51
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$1.32M 0.36%
+165,310
New +$1.32M
PFNX
52
DELISTED
Pfenex Inc.
PFNX
$1.32M 0.36%
213,608
– –
RVLP
53
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$1.25M 0.34%
346,410
– –
AFMD
54
DELISTED
Affimed
AFMD
$1.13M 0.3%
26,794
+10,630
+66% +$446K
HRC
55
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$1.03M 0.28%
9,682
-15,000
-61% -$1.59M
AXSM icon
56
Axsome Therapeutics
AXSM
$6.19B
$603K 0.16%
42,410
-338,402
-89% -$4.81M
VTAK icon
57
Catheter Precision
VTAK
$3.07M
$590K 0.16%
1
-1
-50% -$590K
BPMC
58
DELISTED
Blueprint Medicines
BPMC
$240K 0.06%
+3,000
New +$240K
ATNM icon
59
Actinium Pharmaceuticals
ATNM
$52.4M
$163K 0.04%
11,327
– –
ABT icon
60
Abbott
ABT
$231B
– –
-48,737
Closed -$3.53M
ALGN icon
61
Align Technology
ALGN
$9.7B
– –
-17,847
Closed -$3.74M
AMGN icon
62
Amgen
AMGN
$151B
– –
-17,000
Closed -$3.31M
BDX icon
63
Becton Dickinson
BDX
$54.6B
– –
-16,400
Closed -$3.61M
BMY icon
64
Bristol-Myers Squibb
BMY
$95.2B
– –
-50,000
Closed -$2.6M
CAH icon
65
Cardinal Health
CAH
$35.7B
– –
-209,009
Closed -$9.32M
CI icon
66
Cigna
CI
$80.7B
– –
-52,216
Closed -$9.92M
COR icon
67
Cencora
COR
$57B
– –
-133,934
Closed -$9.97M
ESTA icon
68
Establishment Labs
ESTA
$1.12B
– –
-52,701
Closed -$1.45M
IDXX icon
69
Idexx Laboratories
IDXX
$51.2B
– –
0
– –
ISRG icon
70
Intuitive Surgical
ISRG
$162B
– –
0
– –
KURA icon
71
Kura Oncology
KURA
$704M
– –
-144,411
Closed -$2.03M
LXRX icon
72
Lexicon Pharmaceuticals
LXRX
$382M
– –
0
– –
MASI icon
73
Masimo
MASI
$7.72B
– –
0
– –
NBIX icon
74
Neurocrine Biosciences
NBIX
$13.7B
– –
-69,000
Closed -$4.93M
PEN icon
75
Penumbra
PEN
$10.9B
– –
0
– –
1 2
3
4